Charles River Laboratories (CRL) Q4 Earnings and Revenues Surpass Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $2.39 per share, beating the Zacks Consensus Estimate of $2.33 per share. This compares to earnings of $2.66 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.51%. A quarter ago, it was expected that this medical research equipment and services provider would post earnings of $2.32 per share when it actually produced earnings of $2.43, delivering a surprise ...